Concordance among three programmed death-ligand 1 (PD-L1) scoring methods and their association with clinical outcomes of tislelizumab (TIS) monotherapy in esophageal squamous cell carcinoma (ESCC).

被引：1
|
作者：
Shu, Yongqian
Wang, Jufeng
Chen, Zhendong
Kim, Sung-Bae
Lin, Chen-Yuan
Kato, Ken
Van Cutsem, Eric
Du, Wenting
Shi, Jingwen
Xia, Tianyu
Huang, Ruiqi
Li, Qiao
Zhang, Yun
Shen, Zhirong
Shen, Lin
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Peoples R China
[2] Henan Canc Hosp, Zhengzhou, Peoples R China
[3] Anhui Med Hosp, Hosp 2, Hefei, Peoples R China
[4] Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea
[5] China Med Univ Hosp, Taichung, Taiwan
[6] Natl Canc Ctr, Tokyo, Japan
[7] Univ Hosp Gasthuisberg Leuven, Leuven, Belgium
[8] Univ Leuven, Leuven, Belgium
[9] BeiGene Shanghai Co Ltd, Clin Biomarker, Shanghai, Peoples R China
[10] BeiGene Beijing Co Ltd, Clin Biomarker, Beijing, Peoples R China
[11] BeiGene Beijing Co Ltd, Stat, Beijing, Peoples R China
[12] BeiGene Beijing Co Ltd, Clin Dev, Beijing, Peoples R China
[13] Peking Univ Canc Hosp & Inst, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
3282-3306-2666-6279; 283-424-6846-271-2644; 613-135-2370-7650-2700; 11890-11879-11918-11863; 3282-206-3220-6287; 6; 5; 4; 1614; 2424; 3; 1; 38092-20072; 9;
D O I：
10.1200/JCO.2024.42.3_suppl.390
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：390 / 390
页数：1
相关论文
共 50 条
  • [21] Programmed Death Ligand-1 (PD-L1) Expression in Cervical Squamous Cell Carcinoma: Does it Correlate With Outcomes?
    Monsrud, Ashley L.
    Avadhani, Vaidehi
    Mosunjac, Marina B.
    Flowers, Lisa
    Krishnamurti, Uma
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2023, 42 (06) : 535 - 543
  • [22] Programmed Death-Ligand 1 (PD-L1) Expression in Anal Squamous Cell Carcinoma Used in Combination with HPV Status Further Stratifies Clinical Outcome
    Jamshed, Sarah
    Zhu, Xiaoqin
    Dresser, Karen
    Bledsoe, Jacob
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 687 - 688
  • [23] Programmed Death-Ligand 1 (PD-L1) Expression in Anal Squamous Cell Carcinoma Used in Combination with HPV Status Further Stratifies Clinical Outcome
    Jamshed, Sarah
    Zhu, Xiaoqin
    Dresser, Karen
    Bledsoe, Jacob
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 687 - 688
  • [24] Interobserver Agreement of Programmed Death-Ligand 1 (PD-L1) Scoring in Triple Negative Breast Cancers
    Richards, Stephanie
    Samankan, Shabnam
    Freire, Rochelle
    Reis, Isildinha
    De La Cruz, Anthony
    Jorda, Merce
    Gomez-Fernandez, Carmen
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 143 - 144
  • [25] Prolonged Response of Metastatic Programmed Death-Ligand 1 (PD-L1) Negative Basaloid Squamous Cell Carcinoma of the Lung to Maintenance Immunotherapy
    Fox, Ashley D.
    Ullah, Asad
    Vemavarapu, Lakshmi K.
    Bustamante, Freyli
    Karim, Nagla Abdel
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [26] Interobserver Agreement of Programmed Death-Ligand 1 (PD-L1) Scoring in Triple Negative Breast Cancers
    Richards, Stephanie
    Samankan, Shabnam
    Freire, Rochelle
    Reis, Isildinha
    De La Cruz, Anthony
    Jorda, Merce
    Gomez-Fernandez, Carmen
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 143 - 144
  • [27] Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma
    Chen, Kaiyan
    Cheng, Guoping
    Zhang, Fanrong
    Zhang, Nan
    Li, Dan
    Jin, Jiaoyue
    Wu, Junzhou
    Ying, Lisha
    Mao, Weimin
    Su, Dan
    ONCOTARGET, 2016, 7 (21) : 30772 - 30780
  • [28] Activated interferon-γ (IFN-γ) pathway associated with clinical benefit to programmed cell death protein-1 (PD-1)/PD ligand 1 (PD-L1)-based therapy in esophageal squamous cell carcinoma (ESCC).
    Guo, Jhe-Cyuan
    Hsieh, Min-Shu
    Lin, Chia-Chi
    Huang, Ta-Chen
    Chang, Chun-Jung
    Hsu, Chih-Hung
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [29] Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer
    Bari, Shahla
    Muzaffar, Jameel
    Chan, Austin
    Jain, Sanjay R.
    Haider, Ahmad M.
    Curry, Marjorie Adams
    Hostler, Christopher J.
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [30] miRNA-A and programmed death ligand 1 (PD-L1) expression in oral squamous cell carcinoma
    Hyung, Hong
    Ko, Yoon Ho
    Jin, Lee Hee
    Jeon, Sang Hoon
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345